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The complex responses of cells to stimuli are the aggregate of alterations at the genetic, protein, metabolic and cellular levels.
The immense quantities of data now available from high-throughput genomic, proteomic and metabolomic sources require
specialized analytical approaches. The integration of such data for the computational elucidation and analysis of cellular
pathways and networks is an area of considerable current interest. As the quantity of available data continues to increase,
strategies to extract the useful information from the data will continue to provide answers to important biological questions.
Chemical engineers are actively involved in this ﬁeld that has taken on the global title of “Systems Biology”. These research
groups have made considerable impact from both the computational and experimental standpoints. This commentary
describes some of the recent contributions of chemical engineering researchers to the computational analysis of high-
throughput, multi-source data as described in recent publications and presentations from the 2005 AIChE Annual Meeting.
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1. Introduction
New insights into biological processes arise from both
experimental and analytical innovations. Of particular
recent interest is the generation and analysis of high-
throughput data. This data is taken at many levels, e.g. the
messenger RNA (mRNA) level (genomics), the protein
level (proteomics) and the metabolite level (metabo-
lomics). In each case, the goal of these “-omics”
technologies is the simultaneous and quantitative
measurement of all species in the class. For instance,
genomics technology developments have led to oligo-
nucleotide microarrays that can simultaneously generate
over 500,000 data points from which the expression levels
of over 47,000 unique mRNAs can be determined [1].
Concomitantly, advances in high-throughput data gener-
ation technologies have spurred new thinking and new
approaches to analyzing such data to ensure that maximal
information is extracted. This information potentially
includes points of signaling and metabolic network
connectivity that are too subtle to be detected in the
examination of low-throughput (single gene or a few
genes at a time) experiments. Mathematical tools are
required that can integratevast mRNA, protein, metabolite
and pathway data. This is one powerful way that new
analytical strategies are contributing to the understanding
of biological systems.
By accounting for all of the available data simul-
taneously, statistical inferences of interactions that exist
within a network can be made that would not be identiﬁed
otherwise. A modeling framework offers the ability to
predict cellular function and regulation and describes key
aspects of network functionality, such as robustness, from
the network structure. Numerous mathematical models,
from abstract discrete Boolean networks [2] to detailed
biological mechanistic-based models [3], have been
applied to represent biological networks. Once the
appropriate model framework is identiﬁed, manipulation
of the network becomes a more straightforward task, with
alterations to network components guided by model
predictions.
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metabolic and biological systems can be categorized
into four groups: (i) feature selection, (ii) prediction,
(iii) optimization and (iv) network inference. (i) Feature
selection is used to build a classiﬁcation model that
evaluates patterns in the data and extracts “characteristic
modes or features” within the data. These features are
used to classify the data into groups, e.g. genes of
similar regulation and function or similar cellular state or
biological phenotype. The model, once trained, can then
be used to assign the classiﬁcation for sets of unknown
data. (ii) Prediction is employed to determine, for
instance, the cellular response as a function of the
environmental variables and their genetic and metabolic
proﬁles. Therefore, as these variables change, the model
can predict how the cells will respond to the changes.
(iii) Optimization involves ﬁnding values of the variables
that optimize (maximize or minimize) an objective
function. Variables may include concentrations of
intracellular and extracellular species whose alteration
results in a unique cellular behavior, while the objective
function may be a particular cellular response, such as
growth rate or speciﬁc production of a cellular
component, for which an optimal behavior is desired.
(iv) Network inference refers to the construction of
network connectivity from high-throughput data. Infer-
ring network interactions takes advantage of the
available prior knowledge of the cause–effect relation-
ships among the variables and, from this, proposes
previously unidentiﬁed connections that exist. Knowing
the full extent of the causal relationships among system
components will help properly identify the variables that
should be modulated (and how they should be
modulated) to elicit a speciﬁc cellular or tissue response.
A more detailed knowledge and understanding of the
metabolic and genetic regulatory networks and their
interactions facilitates optimization and prediction of
cellular function for a variety of situations and
conditions. As highlighted in this brief review focusing
on the authors whose work was presented in the
“Computational and Functional Genomics” sessions at
the 2005 Annual AIChE meeting [4,5], a number of
chemical engineering research groups are making
valuable contributions to the computational methods
required for network inference and analysis.
2. Sources of data for computational cellular pathway
analyses
Clearly experimental investigations provide the data to be
analyzed by computational strategies, but experiments
also provide critical constraints of known information that
can improve the utility and accuracy of computational
methods. Recently developed high-throughput data
generation strategies provide the basis for the application
of systems approaches to biological problems. High-
throughput biological information can now be obtained at
some degree for all biological molecules. In addition,
databases of compiled information from both high-
throughput experiments and literature data mining can
provide sample sizes sufﬁcient for the extraction of new
pathway information with statistical signiﬁcance that
would be lacking from small-scale experiments alone.
2.1 Gene expression data
Oligonucleotide (short single-stranded DNA molecules)
and cloned DNA (cDNA) microarrays are well established
for the measurement of genomics data such as mRNA
levels, genomic DNA resequencing, single nucleotide
polymorphism (SNP) detection, etc. (recently reviewed in
[6]). Microarray analyses depend on two unique properties
of nucleic acids: (i) speciﬁc complementarity by Watson–
Crick base-pairing (A:T and G:C) and (ii) mRNA
ampliﬁcation by reverse transcription-polymerase chain
reaction (RT-PCR). Complementarity allows simultaneous
separation of all targets in the sample. Ampliﬁcation
provides sufﬁcient material for detection. For these
reasons, genomics technologies have far outpaced
high-throughput technologies for other cellular molecules,
which do not possess these properties. Hence, systems
biology approaches are still primarily based on
genomics data.
With the quantity of data that is generated by
microarray experiments, it is important to assess the
value of each of the data points in providing classiﬁcation
of biological samples. Those genes that provide the
greatest information in the expression dataset will be most
useful for categorizing new samples in diagnostic
applications. One approach to assessing the value of
each data point is the application of decision trees [7]. In
one study, an algorithm was trained with 63 samples
containing representatives of each of four tumor cell types
catalogued by pathology. It was determined that as few as
three genes could perfectly categorize the samples into the
four unique classes present in the training data. The
method of gene selection proved reproducible with two
genes being selected as most informative in 89 and 67% of
cases, respectively. Each of these genes is known to be
associated with the tumor cell types for which they proved
most discriminatory. However, the genetic and phenotypic
differences among different cancers are often dramatic. It
is not expected that more subtle phenotypic differences
could be accurately classiﬁed with as few informative
genes, butit is expected that the described approach would
minimize the number of genes required for any such
discrimination, guiding more thorough analyses of the
most relevant genes.
2.2 Protein expression and interaction data
Typical proteomic experimental systems take both array-
based and non-array-based forms. In non-array-based
proteomics techniques, separation and detection are per-
formed in distinct operations. Two principal methods for
proteomic separation are two-dimensional electrophoresis
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point (pI), in essence molecular charge, and their size
(molecular weight) and liquid chromatography (LC) [9],
but others have also been used [10]. Following separation,
proteins are identiﬁed by western blotting or single or
tandem mass spectrometry (MS or MS/MS) [9]. Unfortu-
nately, MS does not innately provide quantitative
information about peptide concentrations in a sample
[11]. Recent efforts to establish absolute and relative
quantitation for MS samples, e.g. using peptide standards
and stable isotope labeling techniques such as ICAT and
iTRAQ, are beginning to improve the utility of MS as a
quantitative measure of peptide concentrations [12].
Arrays for protein detection use the same principle of
simultaneous separation as nucleic acid arrays [13].
Protein arrays can be separated into two classes, (i) those
designed to identify interactions of a speciﬁc protein with
other molecules or (ii) those designed to measure many
protein levels in a sample. The ﬁrst class of arrays includes
DNA-binding protein arrays, small molecule arrays for
drug targets, lectin arrays for glycoprotein binding and
protein arrays for protein–protein interactions [13–24].
The second class of arrays typically utilizes antibody–
protein binding for speciﬁc protein separation. Antibody
arrays for classes of proteins, including cytokines, have
been successfully applied [25,26]. However, any approach
based on antibodies will suffer from product variability,
afﬁnity and kinetics limitations, and possible protein
denaturation [27]. Aptamers, RNA molecules that can
speciﬁcally bind proteins like antibodies, have also been
developed for protein measurements on both solid
substrates and conﬁned microspheres [28–34]. Current
aptamer array technologies, though, are in their infancy
relative to DNA microarrays and require specialized
instruments for use, detection and analysis [31,32,34].
Better solutions for array-based proteomics are an area of
considerable current interest and investigation.
In addition to protein expression data, protein–protein
interaction data is critical in identifying connections
among cellular pathways that might not be evident in other
ways. One technique that has proven successful for
assessing protein–protein interactions is termed “the yeast
two-hybrid assay”. The technique is predicated on the fact
that transcription factors have distinct domains for DNA
binding and transcriptional activation (the original
demonstration of the method utilized a factor, GAL4,
speciﬁc for activation of galactose metabolism genes in
yeast [35]). To test whether two proteins, A and B, interact
each of these proteins is conjugated to one domain of the
transcription factor. If the A and B conjugates interact,
then their attached transcription factor domains will be
brought into proximity resulting in the upregulation of
expression from the reporter gene. Though arguments can
arise as to the biological relevance of some of the
measured interactions, the technique provides a robust and
ﬂexible means of identifying those proteins that show
stable intracellular interactions and may, therefore, be
linked in some fashion in a cellular network.
2.3 Metabolomic data
Metabolic data often reﬂects the aggregate activity of the
cellular network and can be a valuable means of
comparing the global effects of different stimuli on cells.
High-throughput metabolic data or metabolomic data, is
typically acquired through combined chromatographic
separation (either GC or LC) and MS [36]. One powerful
approach was recently described that identiﬁed over 5000
metabolites in a 20ml sample using primarily automated
sample handling [9]. As with MS-based proteomics, inter-
and intra-sample comparisons of metabolite concen-
trations are very difﬁcult, requiring addition of complex
internal standards. Nonetheless, the presence or absence
of a particular metabolite of interest in a sample can be
readily established, at least for a single instrument set up
and sample handling protocol [37], and its concentration
quantiﬁed relative to a standard or by more traditional
analytical methods if the importance of the molecule
dictates such scrutiny.
2.4 Molecular interaction databases
Database information collected from many sources is used
to ensure that the overarching biology is accounted for in
computational results. The Kyoto Encyclopedia of Genes
and Genomes (KEGG) database is one of the most highly
utilized [38] and has features akin to those available from
a number of databases that are currently freely available
online. Included in the KEGG database are the proteins
and small molecules involved in major metabolic and
signaling cellular pathways. In addition, sequence,
structure, known functions and localization information
are provided for proteins, when available. Connections
among various cellular components have been built from
the available literature and are continually updated. One
commercial database has combined manual and auto-
mated data collection to yield a curated database that is
proposed to reﬂect biologically relevant pathway infor-
mation more accurately than databases that rely solely on
automated text searching of the literature [39].
3. Construction and analysis of cellular networks
3.1 Signaling networks
Cells respond to environmental and physiological changes
through an extensive transcriptional regulatory network,
which concludes with transcription factors acting on their
target genes. Protein receptors on the outer surface of
cellular membranes bind to speciﬁc ligands present in the
extracellular space and initiate a cascade of events leading
to the activation of transcription factors. These transcrip-
tion factors bind to the promoter regions of speciﬁc genes
to either positively or negatively regulate expression of
those genes. The activities of transcription factors
depend both on the quantity of the transcription factor
proteins present as well as their state of activation.
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expression levels of transcription factors. However,
genome-wide measurement of transcription factor activi-
ties remains a challenge that is being addressed
computationally from a number of unique perspectives.
Typically, a gene is regulated by several different
transcription factors, and the speciﬁc role of each
transcription factor in regulating each gene is not easily
ascertained. Until high-throughput protein analysis
approaches can accomplish this formidable task,
computational strategies are better suited to elucidating
these relationships. One tool for accomplishing this task
is promoter analysis and interaction network tool
(PAINT) [40]. Integrating promoter database information
and genomic data, PAINT returns a network identifying
the “transcriptional regulatory elements” (TREs) for each
gene. TREs provide insight into the coordinated
regulation of each gene through multiple transcription
factor activities. It was determined from two case studies
that the majority of genes have between 8 and 12 TREs,
with the majority of TREs regulating fewer than 10
genes. This indicates that multiple transcription factors
can potentially play redundant, synergistic or antagonistic
roles in affecting gene expression, perhaps providing
ﬁner control of the expression of important genes than
would be achieved with a single TRE. The success of
PAINT also demonstrates the value of integrating multi-
source data for improved understanding of cellular
function.
Another approach to understanding transcription factor
activities and regulation, network component analysis
(NCA), demonstrates the integration of known pathway
information with statistical analysis to improve the
description of the underlying biology [41]. NCA predicts
the function of each transcription factor in the regulation
of the signaling network through a “control strength”. The
method requires no assumptions about the underlying data
structure, unlike independent component analysis (ICA)
and principal component analysis (PCA), and incorporates
known pathway information in the form of statistical
constraints. If the data satisfy three criteria (see online
appendices of [41] for further information), a qualitatively
unique network structure can be obtained. NCA utilizes
available network information to reconstruct unknown
connections that must exist to result in the measured
output signal dynamics. The technique accurately
reconstructed known spectral data in a model case and,
in a biological test, identiﬁed transcription factor activities
during a carbon source transition in E. coli despite little
change in the mRNA expression levels for the transcrip-
tion factor genes. Expression levels of 100 genes were
used to determine the activities of 16 transcription factors
that control those genes. Subsequent experimental results
validated the predicted transcription factor activities.
NCA succeeds in part due to the existing wealth of
information on transcription factor–gene connectivity. As
more such information is generated and validated, NCA
could be applied for the whole-cell determination of
transcription factor activities, which would permit the
formulation of global transcriptional regulatory networks.
One limitation of the initial formulation of NCA was its
inability to incorporate experimental constraints, such as
gene knockouts, into the mathematical formulation.
However, the method has recently been generalized to
make it feasible to include such information [42].
3.2 Integrated metabolic and signaling networks
The interest of chemical engineering groups in the
analysis of genomics data grew from strengths in
metabolic engineering. Numerous mathematical
approaches were developed to analyze the systematic
properties and behavior of complex metabolic networks
and the pathways of which they are comprised [43].
A metabolic pathway consists of enzymatic reactions that
convert reactants (substrates) to products. Each reaction
starts with a substrate(s) and terminates with a product(s).
A substrate can participate in any number of reactions or
pathways. A metabolic network is a linked set of complex
interconnected pathways. Existing literature knowledge is
relied upon heavily to reconstruct or build metabolic
networks (e.g. KEGG). These databases combine genome
sequence data with information on biological function to
reconstruct metabolic pathways.
The quantitative analysis of metabolic networks and
other metabolic engineering techniques have traditionally
been applied tooptimize cellular function primarilyfor the
purposeofenhancingtheproductionofspecialtychemicals
from prokaryotic cells, yeasts, fungi and to some limited
extent, mammalian cells [44,45]. However, prior to the
application of metabolic engineering techniques, the
network map of the metabolic pathways for the cell or
tissue of interest must be constructed. Mapping all the
destinations for a particular enzymatic substrate a priori
would facilitate the building of metabolic networks.
Systems approaches to analyze metabolic network
information quantitatively are gaining in importance.
Information on how cells are regulated and behave under a
given environment is contained within the gene expression
and metabolic proﬁle data, and thus could be readily
captured by an appropriate model. The information
contained within the data includes, the linear and
nonlinear relationships between the external and internal
variables. Systems techniques can help extract this
information from the data and facilitate the reconstruction
of metabolic networks and the coupling of gene regulatory
and signaling pathways to the metabolic networks.
Once relationships among the cellular networks are
identiﬁed, they can be used to instruct how to modulate
tunable variables (gene expression levels, protein activi-
ties and extracellular stimuli) to obtain a desired level of
cellular function or response. Knowledge of the metabolic
network and the interactions among the various networks
(gene, signaling, etc.) facilitates optimization and predic-
tion of cellular processes. Recent work demonstrates two
approaches to integration of signaling and metabolic
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metabolic pathways and simultaneous kinetic modeling of
signaling and metabolic reactions.
Metabolic pathways were successfully reconstructed
using a genetic algorithm/partial least squares (GA/PLS)
approach that integrated metabolic response data,
metabolic pathway information and genomic data [20].
The goal of the study was to identify those genes whose
expression level changes predicted most closely metabolic
data obtained from cells exposed to fatty acids and
hormone-supplemented culture media. The sets of
relevant genes selected by GA/PLS were found to depend
on the initial conditions that were randomly chosen by the
algorithm. GA is a simple and robust algorithm that is able
to ﬁnd solutions rapidly for difﬁcult high-dimensional
problems. GA is an efﬁcient search algorithm when the
search space is large, complex, poorly understood or when
the domain knowledge is scarce. A disadvantage of GA is
that it cannot guarantee an optimum or global solution.
Therefore, to address this limitation, the GA algorithm
was run many times and the frequency with which each
gene was selected was counted to predict a metabolic or
phenotypic response in the PLS model [46]. A cut-off
value of 55% was chosen to identify the genes selected
with a probability higher than random chance. Examining
the biological function of the selected genes, the urea
cycle, tricarboxylic acid (TCA) cycle and metabolic
pathways for triglyceride synthesis were reconstituted.
However, this approach utilized existing network infor-
mation to connect the relevant pathway components.
Approaches that generate a network without prior
connectivity knowledge were thus considered.
It was demonstrated that a Bayesian framework could
reconstruct metabolic networks from metabolic data [47],
and this approach was extended to the reconstruction of
the signaling networks involved in an observed metabolic
response [48].This method requires a largeamount of data
for the network reconstruction. Therefore, an alternative
approach was developed that identiﬁed the active
pathways without interaction measurements and with a
limited amount of data, namely, by integrating gene
expression and metabolic proﬁles. The approach, termed
Three-stage Integrative Pathway Search (TIPS
q), ﬁrst
couples GA/PLS and constrained ICA to identify those
genes that were statistically most likely to be involved in
the process of interest, in this case cell death as
characterized by LDH release. Bayesian network analysis
was then applied to the selected genes to reconstruct
network connectivity. An advantage of this approach is the
coupling of multi-source data, which may capture more of
the cellular state than with gene expression data alone.
This is done at the expense of a reduced sample size,
which can be overcome, if necessary, using techniques
such as interpolation and resampling [49]. Perturbation
analysis identiﬁed genes in the reconstruction network
whose expression levels were uniquely important in
mediating the biological response. Experimental inhi-
bition of these genes validated their connection to the
cytotoxic response, as predicted by the modeling
approach.
Another biological response, biomass accumulation
subsequent to extracellular stimulation, was simulated
using a multi-scale kinetic model based on ﬂux balance
analysis [50]. In this model, an integrated signaling and
metabolic network was built leading to the accumulation
of biomass. Estimates of reaction rate constants for the
various processes that occur (i.e. receptor–ligand
association, phosphorylation, ATP hydrolysis, transcrip-
tional activation/repression, protein synthesis, etc.) were
obtained from the literature [51]. The pseudo-steady-state
assumption was then used for “fast reactions”
(processes/reactions occurring on the order of seconds)
while “slow reactions” (processes/reactions occurring on
the order of minutes or hours) were modeled as occurring
after a time delay of appropriate length in discretized time
units. Biomass accumulation was represented by a
reaction in which the combination of a number of
components in a speciﬁed stoichiometry yielded a
“molecule” of biomass. Alterations in the initial signaling
events were shown to propagate through the network and
alter the rates of biomass accumulation and carbon
depletion. This technique provides a uniﬁed approach
to modeling a uniﬁed signaling and metabolic network by
treating all pathways as chemical reactions of known
kinetics.
4. Conclusions
Biological systems are complex and integrated. Classical
experimental techniques have yielded considerable
information about the key participants in important
signaling and metabolic pathways. The advent of high-
throughput technologies has altered the manner in which
data are collected and subsequently analyzed. Newly
developed analytical techniques take advantage of the
available data as a whole and integrate as many data
sources as possible to characterize the biological situation.
Much recent work has focused on establishing functional
pathways and regulatory roles for the various constituents
of the cellular milieu. With validated statistical models
in hand, system modiﬁcations, such as gene knockouts or
overexpressions, can be tested in silico without the cost
and time expense of laboratory experiments. In this way,
prime targets for intervention, whether they be genetic,
protein activation or metabolic, can potentially be
identiﬁed more directly. As the quantity and quality
of data increases, the value of these approaches will be
further demonstrated.
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